SCHEMBL19632879

SCHEMBL19632879

C=CCOC(=O)[C@@H](CC(C)C)Oc1cccc(C=O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.39
MAOA P21397 7/20 0.38
MAOB P27338 7/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NPC1 O15118 3/20 0.37
RAB9A P51151 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
POLB P06746 2/20 0.37
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
GAA P10253 2/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19632621 1.00 SRC (0.39) SRCMAOAMAOBALDH1A1HPGD
SCHEMBL19632607 0.86 ALDH1A3 (0.50) ALDH1A1HPGDL3MBTL1KDM4EMAPK1
SCHEMBL19632606 0.86 ALDH1A3 (0.50) ALDH1A1HPGDL3MBTL1KDM4EMAPK1
SCHEMBL19632675 0.84 PTGS2 (0.36) ALDH1A1HPGDL3MBTL1KDM4EMAPK1
SCHEMBL19632676 0.84 PTGS2 (0.36) ALDH1A1HPGDL3MBTL1KDM4EMAPK1
SCHEMBL19633024 0.83 TSHR (0.37) ALDH1A1HPGDL3MBTL1KDM4EMAPK1
SCHEMBL19632746 0.83 TSHR (0.37) ALDH1A1HPGDL3MBTL1KDM4EMAPK1
SCHEMBL19632623 0.82 MAOA (0.48) MAOAMAOB
SCHEMBL19633046 0.82 MAOA (0.48) MAOAMAOB
SCHEMBL19632637 0.82 MAOA (0.48) MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190153620-A1 LIBRARIES OF DIVERSE MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME CYCLENIUM PHARMA INC. (CA) 2019-05-23 US disclosed
WO-2017197488-A1 LIBRARIES OF DIVERSE MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME CYCLENIUM PHARMA INC. (CA) 2017-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190153620-A1 LIBRARIES OF DIVERSE MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME VDR, TRPM8, TRPM7 SRC 3330/4885MAOA 3482/4885MAOB 3674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.